These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23805646)

  • 1. [Epidemiologic diagnostic of nosocomial suppurative-septic infections of Pseudomonas etiology based on intraspecies typing of causative agent].
    Fel'dblium IV; Zakharova IuA; Nikolaeva AM; Fedotova OS
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (1):14-20. PubMed ID: 23805646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
    Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
    J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
    Er H; Altındiş M; Aşık G; Demir C
    Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of VIM-4 metallo-β-lactamase-producing Pseudomonas aeruginosa in an Algerian hospital.
    Merradi M; Kassah-Laouar A; Ayachi A; Heleili N; Menasria T; Hocquet D; Cholley P; Sauget M
    J Infect Dev Ctries; 2019 Apr; 13(4):284-290. PubMed ID: 32045372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on prevalence and molecular mechanisms of antibacterial resistance in Gram-negative pathogens of nosocomial infections in hospitals of Moscow and Perm'].
    Mudrak DE; Ikriannikova LN; Sidorenko SV; Il'ina EN
    Antibiot Khimioter; 2007; 52(7-8):10-6. PubMed ID: 18986019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006.
    Patzer JA; Walsh TR; Weeks J; Dzierzanowska D; Toleman MA
    J Antimicrob Chemother; 2009 Feb; 63(2):269-73. PubMed ID: 19095681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTX-M-15 and OXA-10 beta lactamases in multi drug resistant Pseudomonas aeruginosa: First report from Pakistan.
    Ullah W; Qasim M; Rahman H; Khan S; Rehman ZU; Ali N; Muhammad N
    Microb Pathog; 2017 Apr; 105():240-244. PubMed ID: 28258003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
    Martins AF; Zavascki AP; Gaspareto PB; Barth AL
    Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of cytotoxicity effectors in nosocomial Pseudomonas Aeruginosa strains].
    Kuznetsova MV; Maksimova AV; Karpunina TI; Demakov VA
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):9-14. PubMed ID: 25816507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
    Vatcheva-Dobrevska R; Mulet X; Ivanov I; Zamorano L; Dobreva E; Velinov T; Kantardjiev T; Oliver A
    Microb Drug Resist; 2013 Oct; 19(5):355-61. PubMed ID: 23600605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
    Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
    Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Emergence of extended-spectrum beta-lactamases in Pseudomonas aeruginosa: about 24 cases at Rouen University Hospital].
    David M; Lemeland JF; Boyer S
    Pathol Biol (Paris); 2008; 56(7-8):429-34. PubMed ID: 18835668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of SHV-type extended spectrum beta-lactamase genes in Pseudomonas aeruginosa by PCR-restriction fragment length polymorphism and insertion site restriction-PCR].
    Kalai Blagui S; Achour W; Abdeladhim A; Ben Hassen A
    Pathol Biol (Paris); 2009 Jul; 57(5):420-4. PubMed ID: 18838231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal dissemination of Pseudomonas aeruginosa isolates producing extended-spectrum β-lactamase SHV-2a.
    Jeannot K; Fournier D; Müller E; Cholley P; Plésiat P
    J Clin Microbiol; 2013 Feb; 51(2):673-5. PubMed ID: 23241379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of metallo-beta-lactamase-mediated resistance challenging antimicrobial therapy against Pseudomonas aeruginosa in a Brazilian teaching hospital.
    Zavascki AP; Goldani LZ; Gonçalves AL; Martins AF; Barth AL
    Epidemiol Infect; 2007 Feb; 135(2):343-5. PubMed ID: 16824253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
    Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
    J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetic acid as a decontamination method for sink drains in a nosocomial outbreak of metallo-β-lactamase-producing Pseudomonas aeruginosa.
    Stjärne Aspelund A; Sjöström K; Olsson Liljequist B; Mörgelin M; Melander E; Påhlman LI
    J Hosp Infect; 2016 Sep; 94(1):13-20. PubMed ID: 27346622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
    Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM
    J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of Pseudomonas aeruginosa clinical isolates from Korea producing β-lactamases with extended-spectrum activity.
    Bae IK; Suh B; Jeong SH; Wang KK; Kim YR; Yong D; Lee K
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):373-7. PubMed ID: 24792837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.